Elekta announced Monday that its Board of Directors has appointed Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
Just-Bomholt, a Danish citizen, will join Elekta in August for onboarding and will be based in Stockholm, the company said.
He will work closely with the current Acting CEO, Jonas Bolander, and the management team during the transition.
According to Elekta, Just-Bomholt has a strong track record as an experienced international executive, most recently serving as CEO of 3Shape, a Danish company specializing in 3D scanning and CAD/CAM software for the dental industry.
Prior to that, he held senior executive positions at Falck A/S and A/P Moller Maersk.
Dr Laurent Leksell, Elekta’s Founder and Chairman of the Board of Directors, said: "We are delighted to welcome Jakob Just-Bomholt to Elekta. His strategic leadership and international experience, combined with a proven ability to drive profitable growth and global expansion through customer-focused innovation and operational excellence, make him very well-suited to lead Elekta forward."
Leksell added, "The Board is confident in Jakob’s ability to guide the company into its next chapter and deliver value to our shareholders, customers, and the cancer patients we serve around the world.”
Jakob Just-Bomholt commented: "I am honored to join Elekta, a company with a proud legacy and a powerful mission to improve the lives of people with cancer. Radiation therapy plays a vital role in modern oncology, and I look forward to working with the talented team at Elekta to continue delivering life-changing solutions to patients around the world."
He further stated, "Elekta holds a strong market position, industry leading product portfolio, and considerable growth potential. I look forward to guiding the company in delivering long-term value for all our stakeholders."
More from this issuer
Related coverage
Elekta's new chief executive is replacing three top executives, including the finance chief, in a broad management overhaul aimed at improving the Swedish medical-device maker's performance.
Elekta AB has introduced a new long-term incentive plan that ties executive bonuses to the sales of its advanced radiation-therapy technology, a move approved at its annual general meeting on Thursday.
Elekta AB reported a drop in first-quarter sales and profit margins, setting a challenging backdrop for incoming Chief Executive Jakob Just-Bomholt.
Elekta AB said it received U.S. regulatory clearance for its Leksell Gamma Knife radiosurgery system to treat a form of drug-resistant epilepsy in adults.